Trials / Completed
CompletedNCT03436979
The NeuGuide™ System for Vaginal Colpopexy in the Treatment of Uterine Prolapse
The NeuGuide™ System for Vaginal Colpopexy in the Treatment of Uterine Prolapse Post-Market Surveillance Clinical Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Pop Medical Solutions · Industry
- Sex
- Female
- Age
- 36 Years – 84 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to assess the long term safety, durability of clinical effectiveness and cost effectiveness of the NeuGuide™ system when used for vaginal colpopexy in the treatment of uterine prolapse.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NeuGuide™ System | The NeuGuide™ device is indicated for anchoring sutures to ligaments of the pelvic floor. |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2023-10-31
- Completion
- 2023-10-31
- First posted
- 2018-02-19
- Last updated
- 2025-08-07
Locations
15 sites across 3 countries: United States, Germany, Israel
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03436979. Inclusion in this directory is not an endorsement.